Evaluation of serum leptin levels in diabetic and hypertensive subjects resident in Port Harcourt

Helen A. Waribo; Tamaradoubrah F. Melex; Uchechukwu A. Obisike; Elekima Ibioku; Donatus O. Onwuli

doi:10.18203/2320-6012.ijrms20233012

Authors

Helen A. Waribo Department of Medical Laboratory Science, Rivers State University, Nkpolu Oroworukwo, Port Harcourt, Rivers State, Nigeria
Tamaradoubrah F. Melex Department of Medical Laboratory Science, Rivers State University, Nkpolu Oroworukwo, Port Harcourt, Rivers State, Nigeria
Uchechukwu A. Obisike Department of Medical Laboratory Science, Rivers State University, Nkpolu Oroworukwo, Port Harcourt, Rivers State, Nigeria
Elekima Ibioku Department of Medical Laboratory Science, Rivers State University, Nkpolu Oroworukwo, Port Harcourt, Rivers State, Nigeria
Donatus O. Onwuli Department of Medical Laboratory Science, Rivers State University, Nkpolu Oroworukwo, Port Harcourt, Rivers State, Nigeria

DOI:

https://doi.org/10.18203/2320-6012.ijrms20233012

Keywords:

Diabetes, Hypertensive, Metabolic state, Serum leptin

Abstract

Background: Diabetes and hypertension which are metabolic conditions are becoming more common and prevalent in the world. Prolonged rise of blood sugar levels, is a hallmark of diabetes, a metabolic condition caused by problems with insulin production, insulin resistance or both while hypertension is the persistent high blood pressure in the arteries. Leptin is a hormone that inhibits appetite, reduces fat storage in adipocytes and aids in the regulation of energy balance hence implicated in diabetes and insulin resistance. Thus, can metabolic state affects its level in the serum.

Methods: The study population is two hundred and forty (240) subjects that are residents of Port Harcourt aged between 30-70 years. Sixty subjects were used as the control, sixty subjects were diabetes, the other sixty subjects were hypertensive while the remaining sixty were subjects with both hypertension and diabetic mellitus. An enzyme-linked immunosorbent assay (ELISA) method was used to quantitatively measure leptin levels in the serum sample, glycated haemoglobin were determined quantitatively using sandwich immunodetection and blood pressure was measured using mercury sphygmomanometer.

Results: The data generated were statistically analysed using Graph Pad Prism version 9.0.2. The results showed no significant difference in leptin levels in diabetics, hypertensive and subjects having both diabetes and hypertension when compared with the control subjects having none of these metabolic disorders (p =0.4166).

Conclusions: Our results shows that leptin levels in the population were relatively within the reference ranges both for males (0.5-12ng/ml) and females (0.5-15ng/ml). It clearly shows that metabolic conditions (diabetes or hypertension) does not affect leptin levels in serum.

Metrics

Metrics Loading ...

References

Vrdoljak J, Kumric M, Vilovic M, Martinovic D , Rogosic V, Borovac JA, et al. Can fasting curb the metabolic syndrome epidemic? Nutrients. 2022;14(3):456-60.

Farag YMK Gaballa MR. Diabesity: an overview of a rising epidemic. Nephrol Dial Transplant. 2011;26(1):28-35.

Smyth S. Heron A. Diabetes and obesity: the twin epidemics. Nat Medi. 2006;12(1):75-80.

Devendra D, Liu E, Eisenbarth GS. Type 1 diabetes: recent developments. Biomed J. 2004;328(7442):750-4.

Onwuli DO, Waribo HA, Anyalebechi EO, Nwafor LU. Evaluation of plasma homocysteine levels in type ii diabetes and hypertensive patients attending university of Port Harcourt teaching hospital, Nigeria. J Biosci Medi. 2023;11(5):30-9.

International Diabetes Federation (IDF). Diabetes Atlas. 8th ed. International Diabetes Federation, Brussels; 2017.

World Health Organization. Hypertension, 2023. Available at https://www.who.int/news-room/fact-sheets/detail/hypertension.accessed 25th September 2023.

Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Canad J Cardiol. 2018;34(5):575-84.

Morton GJ. Schwartz, MW. Leptin and the central nervous system control of glucose metabolism. Physiol Revi. 2013;91(2):389-411.

Bouret S, Levin BE, Ozanne SE. Gene-environment interactions controlling energy and glucose homeostasis and the developmental origins of obesity. Physiol Revi. 2015;95(1):47-82.

Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995;269(5223):543-6.

Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes. 2016;45(4):531-5.

Lu SC, Akanji AO. Leptin, obesity, and hypertension: a review of pathogenetic mechanisms. Metab Synd Relat Dis. 2020;18(9):399-405.

Shibasaki K, Yamada S, Akishita M. Plasma leptin concentration and sympathetic nervous activity in older adults with physical dysfunction. J Endocr Soci. 2018;2(9):1040-9.

Ma D, Feitosa MF, Wilk JB, Laramie JM, Yu K, Leiendecker-Foster C, et al. Leptin is associated with blood pressure and hypertension in women from the national heart, lung, and blood institute family heart study. Hypertension. 2009;53(3):473-9.

da Silva AA, do Carmo JM, Hall JE. Role of leptin and central nervous system melanocortins in obesity hypertension. Curr Opini Nephrol Hypert. 2013;22:135-40.

Ghantous CM, Azrak Z, Hanache S. Differential role of leptin and adiponectin in cardiovascular system. Int J Endocrinol. 2015;2015:534320.

Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, Rozen R. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nature Genet. 1994;7(2):195-200.

Bravo PE, Morse S, Borne DM, Aquilar EA, Reisin E. Leptin and hypertension in obesity. Vascular Health Risk Manag. 2006;2(2):163-9.

Mohiti J Doudi J. Relationship between leptin and Insulin in patients with type 2 Diabetes. Turk J Endocrinol Metabol. 2003;9(2):55-8.

Kadhim RS. Determination of leptin level with other biochemical parameters in type 2 diabetic patients world bulletin of public health. W Bullet Pub Health. 2022;13:168-71.

Buyukbese MA, Cetinkaya A, Kocabas R, Guven A, Tarakcioglu M. Leptin levels in obese women with and without type 2 diabetes mellitus. Mediat Inflammat. 2004;13(5-6):321-5.

Das P, Bhattacharjee D, Bandyopadhyay SK, Bhattacharya G, Singh R. Association of obesity and leptin with insulin resistance in type 2 diabetes mellitus in Indian population. Ind J Physiol Pharmacol. 2013;57(1):45-50.

Chen GC, Qin LQ, Ye JK. Leptin levels and risk of type 2 diabetes: gender-specific meta-analysis: Meta-analysis of leptin and type 2 diabetes. Obes Revi: J Int Associat Stu Obes. 2014;15(2):134-42.

Haffner SM, Stern MP, Miettinen H, Wei M, Gingerich RL. Leptin concentrations in diabetic and non diabetic Mexican-Americans. Diabetes. 1996;45(6):822-4.

Sayeed MA, Azad Khan AK, Mahtab H, Ahsan KA, Banu A, Khanam PA, et al. Leptin is reduced in lean subjects with type 2 diabetes in Bangladesh. Diab Care. 2003;26(2):547.

Banerji MA, Faridi N, Atluri R, Chaiken RL Lebovitz HE. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metabol. 1999;84(1):137-44.

Zhao S, Kusminski CM, Elmquist JK, Scherer PE. Leptin: less is more. Diabet. 2020;69(5):823-9.

Söderberg S, Zimmet P, Tuomilehto J, Chitson P, Gareeboo H, Alberti KG, et al. Leptin predicts the development of diabetes in Mauritian men, but not women: a population–based study. Inte J Obes. 2007;31(7):1126-33.

Haynes WG, Sivitz WI, Morgan DA, Walsh SA, Mark AL. Sympathetic and cardiorenal actions of leptin. Hypertension. 1997;30(3):619-23.

Shankar A, Xiao J. Positive relationship between plasma leptin level and hypertension. Hypertension. 2010;56(4):623-8.

Shanker J, Rao VS, Ravindran V, Dhanalakshmi B, Hebbagodi S, Kakkar VV. Relationship of adiponectin and leptin to coronary artery disease, classical cardiovascular risk factors and atherothrombotic biomarkers in the IARS cohort. Thromb Haemost. 2012;108(10):769-80.

Ahren B, Larsson H, Wilhelmsson C, Nasman B, Olsson T. Regulation of circulating leptin in humans. Endocr. 1997;7(1):1-8.

Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F, et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metabol. 1996;81(9):3424-7.

Liuzzi A, Savia G, Tagliaferri M, Lucantoni R, Berselli ME, Petroni ML, et al. Serum leptin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors. Int J Obes Relat Metabol Disor. 1999;23(10):1066-73.